For example, one paper suggests that targeting ROCK2, an actin-binding protein, may be therapeutic for Alzheimer’s disease by inducing autophagy, thereby reducing neurofibrillary tangles and enhancing plasticity of the spine, which is maintained in shape by actin (Weber and Herskowitz, 2021). Here, ROCK2 is linked to early-onset autosomal dominant Alzheimer disease.